Jaguar Health Q1 2024 GAAP EPS $(0.06) Misses $(0.03) Estimate, Sales $2.351M Miss $2.958M Estimate
Portfolio Pulse from Benzinga Newsdesk
Jaguar Health reported its Q1 2024 earnings with a GAAP EPS of $(0.06), missing the $(0.03) estimate. Sales were $2.351M, also missing the expected $2.958M.
May 14, 2024 | 11:01 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Jaguar Health's Q1 2024 earnings report showed both a miss in GAAP EPS and sales against analyst estimates, indicating potential challenges in its financial performance.
Missing both EPS and sales estimates can be seen as a negative indicator of the company's financial health and operational performance, likely leading to negative investor sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100